Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

Clinical trial NCT04704947 · RECRUITING

Trial details

NCT number: NCT04704947
Sponsor: Sherief Abd-Elsalam
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Beta Blocker Toxicity

Start date: 2017-10-01
Primary completion: 2030-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.